These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 16525066)

  • 1. Long-term treatment of Hashimoto's encephalopathy.
    Marshall GA; Doyle JJ
    J Neuropsychiatry Clin Neurosci; 2006; 18(1):14-20. PubMed ID: 16525066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Undetected Hashimoto encephalopathy--a diagnostic challenge in child psychiatry and child neurology].
    Voll R
    Z Kinder Jugendpsychiatr Psychother; 2010 Jan; 38(1):21-7. PubMed ID: 20047173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anti-NAE autoantibodies and clinical spectrum in Hashimoto's encephalopathy].
    Matsunaga A; Yoneda M
    Rinsho Byori; 2009 Mar; 57(3):271-8. PubMed ID: 19363998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hashimoto's encephalopathy : epidemiology, pathogenesis and management.
    Mocellin R; Walterfang M; Velakoulis D
    CNS Drugs; 2007; 21(10):799-811. PubMed ID: 17850170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic and therapeutic aspects of Hashimoto's encephalopathy.
    Olmez I; Moses H; Sriram S; Kirshner H; Lagrange AH; Pawate S
    J Neurol Sci; 2013 Aug; 331(1-2):67-71. PubMed ID: 23759502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hashimoto's encephalopathy: report of three cases.
    Chang JS; Chang TC
    J Formos Med Assoc; 2014 Nov; 113(11):862-6. PubMed ID: 25443353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical manifestations, diagnostic criteria and therapy of Hashimoto's encephalopathy: report of two cases.
    Mijajlovic M; Mirkovic M; Dackovic J; Zidverc-Trajkovic J; Sternic N
    J Neurol Sci; 2010 Jan; 288(1-2):194-6. PubMed ID: 19846119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocrine encephalopathy.
    Yong KW; Soule S; Hunt P
    N Z Med J; 2014 May; 127(1394):85-7. PubMed ID: 24929574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebellar subacute syndrome due to corticosteroid-responsive encephalopathy associated with autoimmune thyroiditis (also called "Hashimoto's encephalopathy").
    Passarella B; Negro C; Nozzoli C; De Marco V; Rini A
    Clin Ter; 2005; 156(1-2):13-7. PubMed ID: 16080655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hashimoto encephalopathy in pediatric patients: Homogeneity in clinical presentation and heterogeneity in antibody titers.
    Lee J; Yu HJ; Lee J
    Brain Dev; 2018 Jan; 40(1):42-48. PubMed ID: 28784301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steroid-responsive autoimmune encephalopathy associated with autoimmune thyroiditis (SREAT) presenting with myoclonus-dystonia syndrome.
    Rožanković PB; Rožanković M; Šušak I; Vlahović I; Sporis D
    J Neurol Sci; 2015 Jul; 354(1-2):110-1. PubMed ID: 25982498
    [No Abstract]   [Full Text] [Related]  

  • 12. Hashimoto's encephalopathy: a rare pediatric brain disease.
    Farrell RM; Foster MB; Omoruyi AO; Kingery SE; Wintergerst KA
    J Pediatr Endocrinol Metab; 2015 May; 28(5-6):721-4. PubMed ID: 25581742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steroid responsive encephalopathy associated with autoimmune thyroiditis (SREAT) in childhood.
    Patnaik SK; Upreti V; Dhull P
    J Pediatr Endocrinol Metab; 2014 Jul; 27(7-8):737-44. PubMed ID: 24598831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hashimoto's encephalopathy in children and adolescents.
    Erol I; Saygi S; Alehan F
    Pediatr Neurol; 2011 Dec; 45(6):420-2. PubMed ID: 22115010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyrotoxic autoimmune encephalopathy in a female patient: only partial response to typical immunosuppressant treatment and remission after thyroidectomy.
    Yuceyar N; Karadeniz M; Erdogan M; Copur A; Akgun A; Kumral E; Ozgen G
    Clin Neurol Neurosurg; 2007 Jun; 109(5):458-62. PubMed ID: 17395366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Reversible white matter lesions and antithyroid antibodies in the cerebrospinal fluid in Hashimoto's encephalopathy: a case report].
    Wakai M; Nishikage H; Goshima K
    Rinsho Shinkeigaku; 2004 Jul; 44(7):432-7. PubMed ID: 15384704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hashimoto's ophthalmopathy.
    Tateno F; Sakakibara R; Kishi M; Ogawa E
    Am J Med Sci; 2011 Jul; 342(1):83-5. PubMed ID: 21701269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Variable manifestations of Hashimoto's encephalopathy].
    van Oostrom JC; Schaafsma A; Haaxma R
    Ned Tijdschr Geneeskd; 1999 Jun; 143(25):1319-22. PubMed ID: 10416487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent status epilepticus as the main feature of Hashimoto's encephalopathy.
    Ferlazzo E; Raffaele M; Mazzù I; Pisani F
    Epilepsy Behav; 2006 Feb; 8(1):328-30. PubMed ID: 16343998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hashimoto encephalopathy: steroid-sensitive encephalopathy in Hashimoto thyroiditis].
    Hartmann M; Schaner B; Scheglmann K; Bücking A; Pfister R
    Nervenarzt; 2000 Jun; 71(6):489-94. PubMed ID: 10919146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.